This study compared the multiring detector (Ring-PET) and the dual-head, co
incidence imaging system (DH-PET) for staging/restaging neoplastic patients
before or after surgery or radiochemotherapy. Methods: Seventy patients wi
th suspected tumor recurrence or metastatic dissemination received an intra
venous dose of F-18-fluorodeoxyglucose (FDG) under overnight fasting and we
re studied in sequence with a dedicated positron emission tomograph with Ri
ng-PET and a DH-PET. Ring-PET studies were performed 45-75 min postinjectio
n and were followed by a DH-PET scan similar to 3 h postinjection. Number a
nd location of the hypermetabolic lesions detected on DH-PET and Ring-PET r
econstructed images were blindly assessed by three independent observers. R
esults: DH-PET identified all 14 head lesions detected by Ring-PET, 53 of 6
3 thoracic lesions and 36 of 45 abdominal lesions. Of the 19 lesions not id
entified by DH-PET, 6 were smaller than 10 mm, 8 were between 10 and 15 mm
and 1 was 18 mm; dimensions of 4 bone lesions were not available. A concord
ant restaging, based on location and number of lesions detected, was found
in ail 14 patients with head tumors, in 28 of 30 patients with thoracic tum
ors and in 24 of 26 patients with abdominal tumors. Conclusion: We found a
good agreement between Ring-PET and DH-PET assessment of oncologic patients
in detecting hypermetabolic lesions greater than or equal to 10-15 mm.